Dr. Kocoglu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-2632Fax+1 410-328-6896
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2003 - 2006
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1999 - 1999
- Hacettepe University FOMClass of 1996
Certifications & Licensure
- MD State Medical License 2014 - 2026
- CT State Medical License 2010 - 2015
- AR State Medical License 2006 - 2011
Publications & Presentations
PubMed
- 1 citationsA novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.Djordje Atanackovic, Thierry Iraguha, Destiny Omili, Stephanie V Avila, Xiaoxuan Fan
Cytotherapy. 2024-04-01 - 92 citationsIdecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.Doris K Hansen, Surbhi Sidana, Lauren C Peres, Christelle Colin Leitzinger, Leyla Shune
Journal of Clinical Oncology. 2023-04-10 - 151 citationsPembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma.Ashraf Z. Badros, Elizabeth Hyjek, Ning Ma, Alexander M. Lesokhin, Ahmet Dogan
Blood. 2017-09-07
Abstracts/Posters
- Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain BarrierMehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...Mehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: